Literature DB >> 914950

Ion-pair liquid chromatography of steady-state plasma levels of chlorimipramine and demethylchlorimipramine.

B Mellström, G Tybring.   

Abstract

A method for the determination of chlorimipramine and its metabolite demethylchlorimipramine in the plasma of depressed patients during treatment is described. The method involves extraction of the parent drug, its metabolite and the internal standard from plasma, back-extraction into an acidic aqueous phase and re-extraction into a small volume of organic phase. Separation and quantitation are carried out by ion-pair partition chromatography with UV detection. Accurate determination if possible down to levels of 30 and 60 nmole per liter of plasma for chlorimipramine and the metabolite, respectively, when 1 ml of plasma is used. The coefficient of variation is 7.3% or less at different levels for chlorimipramine and demethylchlorimipramine. Plasma levels of the parent drug and the metabolite measured by this liquid chromatographic method and by a gas chromatographic procedure with electron-capture detection were in good agreement (r = 0.98). The steady-state plasma level of the metabolite was always higher than that of the parent drug in the 34 depressed patients investigated. The mean ratio between the metabolite and the parent drug was 2.7 +/- 1.1 (S.D.) Large inter-individual differences in the levels of the two compounds in patients receiving similar doses were found.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914950     DOI: 10.1016/s0378-4347(00)81314-6

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

Review 1.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of clomipramine.

Authors:  A E Balant-Gorgia; M Gex-Fabry; L P Balant
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

3.  Do evacuated blood collection tubes interfere with therapeutic drug monitoring?

Authors:  R Janknegt; J J Lohman; P M Hooymans; F W Merkus
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

4.  Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.

Authors:  S B Ross; A Aberg-Wistedt
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Biochemical effects of zimelidine in man.

Authors:  L Bertilsson; J R Tuck; B Siwers
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.